Trujillo Reyes J, Martinez Tellez E, Belda Sanchis J, Planas Canovas G, Libreros Nino A, Guarino M
Front Neurol. 2024; 15:1309173.
PMID: 38361645
PMC: 10867208.
DOI: 10.3389/fneur.2024.1309173.
Weissferdt A, Moran C
Virchows Arch. 2016; 469(3):245-54.
PMID: 27255665
DOI: 10.1007/s00428-016-1967-0.
Elmore S, Cora M, Gruebbel M, Hayes S, Hoane J, Koizumi H
Toxicol Pathol. 2014; 43(1):10-40.
PMID: 25385331
PMC: 4310770.
DOI: 10.1177/0192623314555526.
Gomez A, Willcox N, Vrolix K, Hummel J, Nogales-Gadea G, Saxena A
J Immunol. 2014; 193(3):1055-1063.
PMID: 24973445
PMC: 4143753.
DOI: 10.4049/jimmunol.1301555.
Leite M, Jones M, Strobel P, Marx A, Gold R, Niks E
Am J Pathol. 2007; 171(3):893-905.
PMID: 17675582
PMC: 1959483.
DOI: 10.2353/ajpath.2007.070240.
'Split tolerance' induction by intrathymic injection of acetylcholine receptor in a rat model of autoimmune myasthenia gravis; implications for the design of specific immunotherapies.
Ohtsuru I, Matsuo H, Fukudome T, Suenaga A, Tsujihata M, Nagataki S
Clin Exp Immunol. 1995; 102(3):462-7.
PMID: 8536358
PMC: 1553389.
DOI: 10.1111/j.1365-2249.1995.tb03838.x.
Myasthenia gravis: overlap with 'polyendocrine' autoimmunity.
Scherbaum W, Schumm F, Maisch B, Muller C, Fluchter S, SEIF F
Klin Wochenschr. 1983; 61(10):509-15.
PMID: 6876683
DOI: 10.1007/BF01488718.
Thymectomy in myasthenia gravis. A review.
OOSTERHUIS H
Ital J Neurol Sci. 1983; 4(4):399-407.
PMID: 6370908
DOI: 10.1007/BF02125618.
The immunohistology of the thymus in myasthenia gravis.
Kornstein M, Brooks J, Anderson A, Levinson A, Lisak R, Zweiman B
Am J Pathol. 1984; 117(2):184-94.
PMID: 6208785
PMC: 1900444.
[Lymph follicles in the thymus in cases of ulcerative colitis].
CESNIK H, SCHMID K
Langenbecks Arch Chir. 1971; 328(2):128-38.
PMID: 5554677
DOI: 10.1007/BF01877666.
[Experimental thymitis, myocarditis and polymyositis. A contribution to the pathogenesis of myasthenia gravis Erb].
Griss P, Fahr K
Arch Kreislaufforsch. 1970; 63(3):257-65.
PMID: 4928860
Thyrotoxic muscle disease.
Ramsay I
Postgrad Med J. 1968; 44(511):385-97.
PMID: 4871773
PMC: 2466597.
DOI: 10.1136/pgmj.44.511.385.
[The pathogenesis of myasthenia gravis as an immunological problem].
Kalden J
Klin Wochenschr. 1970; 48(1):4-13.
PMID: 4330544
DOI: 10.1007/BF01486122.
[Thymectomy in the management of myasthenia].
BALZEREIT F, Bay V, Otto H, RITTMEYER P, Sobirey C
Z Neurol. 1972; 201(2):136-59.
PMID: 4112645
Thymic hyperplasia. I. True thymic hyperplasia. Review of the literature.
Hofmann W, Moller P, Otto H
Klin Wochenschr. 1987; 65(2):49-52.
PMID: 3560787
DOI: 10.1007/BF01745472.
Thymopoietin to thymopentin: experimental studies.
Goldstein G, Audhya T
Surv Immunol Res. 1985; 4 Suppl 1:1-10.
PMID: 2994196
DOI: 10.1007/BF02919050.
Desensitization of the nicotinic acetylcholine receptor: molecular mechanisms and effect of modulators.
Ochoa E, Chattopadhyay A, McNamee M
Cell Mol Neurobiol. 1989; 9(2):141-78.
PMID: 2663167
PMC: 11567434.
DOI: 10.1007/BF00713026.
Thymic hyperplasia. II. Lymphofollicular hyperplasia of the thymus. An immunohistologic study.
Hofmann W, Moller P, Otto H
Klin Wochenschr. 1987; 65(2):53-60.
PMID: 2435953
DOI: 10.1007/BF01745473.
Radiologic evaluation of the thymus in juvenile myasthenia gravis.
Thurmond A, Brasch R
Pediatr Radiol. 1978; 7(3):136-40.
PMID: 714525
DOI: 10.1007/BF00975435.
Assessment of the value of thymic scan in myasthenia gravis.
TESTA G, Angelini C
J Neurol. 1979; 220(1):21-9.
PMID: 84064
DOI: 10.1007/BF00313145.
